{"id":"W4376132330","doi":"10.1182/bloodadvances.2023009748","title":"<i>FLT3-ITD</i> does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years","year":2023,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Genentech; Servier; Astellas Pharma; Sierra Oncology; Incyte; Boston Pharmaceuticals; bluebird bio; Bristol-Myers Squibb; Foghorn Therapeutics; Jazz Pharmaceuticals; Gilead Sciences; Amgen; Pfizer; Agios Pharmaceuticals; GlaxoSmithKline","keywords":"Myeloid leukemia; Medicine; Internal medicine; Leukemia; Oncology; Myeloid","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006986574,0.0003298951,0.0009298566,0.0004325076,0.001213847,0.000980182,0.0006003058,0.006163165,0.005938085],"category_scores_gemma":[0.004913398,0.0002037314,0.0005920285,0.0007834738,0.0006514048,0.0006459361,0.0003142818,0.004282679,0.003775822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001454995,"about_ca_system_score_gemma":0.001649318,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01029989,"about_ca_topic_score_gemma":0.01949622,"domain_scores_codex":[0.9995492,0.00009521568,0.00004967004,0.00007788179,0.0001015549,0.0001264486],"domain_scores_gemma":[0.9983047,0.0007190665,0.0001985017,0.0000690609,0.0002813841,0.0004273231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0009928449,0.0001295147,0.1630967,0.0001010261,0.00008659685,0.01306693,0.0001441283,0.0002682089,0.001193833,0.002079302,0.7741852,0.04465571],"study_design_scores_gemma":[0.001492936,0.0009604151,0.4063029,0.0008985693,0.0006076341,0.04093653,0.001411821,0.003312296,0.001225419,0.01951645,0.5231364,0.0001985472],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.05872046,0.003950928,0.0003183802,0.8667405,0.02259346,0.00005587612,0.003718168,0.0001568465,0.04374542],"genre_scores_gemma":[0.3312864,0.003658679,0.0006858751,0.5781424,0.06562714,0.0001084307,0.002051794,0.0001027208,0.01833662],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01029989,"threshold_uncertainty_score":0.02047986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0136208859755537,"score_gpt":0.2750904126672631,"score_spread":0.2614695266917094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}